Apollo Hospitals Enterprise Limited has announced its board's approval for establishing a multi-speciality hospital at Dwarka, New Delhi, marking a significant expansion in the National Capital Region. The decision was taken during the Board of Directors meeting held on April 2, 2026, which commenced at 4:00 p.m. and concluded at 5:45 p.m.

Project Overview

The multi-speciality hospital project will be developed on a substantial land parcel measuring 9.33 acres, which is being leased from the Delhi Development Authority (DDA). The project represents Apollo Hospitals' strategic expansion into one of Delhi's prominent residential and commercial hubs.

Lease Agreement Terms

The land lease arrangement with the Delhi Development Authority encompasses several key provisions that will govern the project's development and operations. The agreement establishes a long-term commitment for healthcare infrastructure development in the region.

Implementation Strategy

The hospital project will be implemented through a phased approach, allowing for systematic development and gradual scaling of healthcare services. Apollo Hospitals plans to incorporate a Special Purpose Vehicle (SPV) specifically for the execution and implementation of this project, ensuring focused management and operational efficiency.

The development will focus on creating a super specialty hospital with allied healthcare services, positioning it as a comprehensive healthcare destination in the Dwarka area. The formal License Agreement is expected to be executed within one year of the board approval.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The project involves a domestic entity arrangement with no related party transactions or promoter group interests in the land-awarding authority.

This expansion initiative reinforces Apollo Hospitals' commitment to extending quality healthcare infrastructure across key metropolitan areas, with the Dwarka facility expected to serve the growing healthcare needs of Delhi's western corridor.

Apollo Hospitals Enterprise Limited has announced that its material subsidiary Apollo Healthco Limited has successfully acquired Apollo Consumer Products Limited, marking a strategic entry into the fast-moving consumer goods sector. The acquisition was completed through a cash transaction valued at INR 9.00 lakhs.

Acquisition Details

The transaction involved Apollo Healthco Limited acquiring 90,000 equity shares of Apollo Consumer Products Limited at face value, representing 100% of the issued and paid-up capital. The shares were purchased from existing shareholders at INR 10/- per share, totaling INR 9.00 lakhs.

Company Structure and Ownership

Following the acquisition, Apollo Consumer Products Limited has become a wholly owned subsidiary of Apollo Healthco Limited and a step-down subsidiary of Apollo Hospitals Enterprise Limited. Apollo Healthco Limited is an unlisted material subsidiary in which Apollo Hospitals holds a 78.88% equity stake on a fully-diluted basis.

Business Operations and Objectives

Apollo Consumer Products Limited, incorporated on March 11, 2026, will engage in comprehensive FMCG operations. The company's business scope includes:

• Trading, distribution, and sale of fast-moving consumer goods
• Food and beverages, personal care, and home care products
• Healthcare and wellness products, baby care items
• Supply chain management, warehousing, and logistics services

The business operations will be conducted through multiple channels, including physical retail outlets, distribution networks, and digital platforms such as e-commerce and direct-to-consumer models.

Financial Structure

The newly acquired company has an authorized share capital of INR 5.00 crores, consisting of 50.00 lakh equity shares of INR 10/- each. The subscribed, issued, and paid-up capital stands at INR 9.00 lakhs, comprising 90,000 equity shares of INR 10/- each.

Regulatory Compliance

The acquisition was disclosed pursuant to Regulation 30 of the Securities and Exchange Board of India Listing Regulations, 2015. The transaction falls within the ambit of related party transactions and was undertaken at arm's length. No governmental or regulatory approvals were required for completing this acquisition, and the transaction has been fully completed.